- Home
- BYRN vs FBIO Comparison
BYRN vs FBIO Comparison
Compare BYRN & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BYRN | FBIO |
|---|---|---|
| Founded | 2005 | 2006 |
| Country | United States | United States |
| Employees | N/A | 78 |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 136.3M | 113.6M |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | BYRN | FBIO |
|---|---|---|
| Price | $3.35 | $3.37 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $23.17 | $17.00 |
| AVG Volume (30 Days) | ★ 1.0M | 611.0K |
| Earning Date | 04-09-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $16,566,295.00 | N/A |
| Revenue This Year | $4.98 | $55.22 |
| Revenue Next Year | $16.86 | $40.55 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1692.08 | N/A |
| 52 Week Low | $3.37 | $1.77 |
| 52 Week High | $30.62 | $4.53 |
Technical Indicators
Market Signals| Indicator | BYRN | FBIO |
|---|---|---|
| Relative Strength Index (RSI) | 25.78 | 58.98 |
| Support Level | N/A | $3.28 |
| Resistance Level | $6.96 | $3.80 |
| Average True Range (ATR) | 0.53 | 0.22 |
| MACD | -0.29 | 0.03 |
| Stochastic Oscillator | 1.38 | 59.46 |
Price Performance
Historical ComparisonAbout BYRN Byrna Technologies Inc.
Byrna Technologies Inc is a designer, manufacturer, retailer, and distributor of technological solutions for security situations that do not require the use of lethal force. The company generates its revenue from the United States, South Africa, Europe, South America, Asia, and Canada.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.